BioNTech SE EBIT 2019-2024 | BNTX

BioNTech SE EBIT for the quarter ending September 30, 2024 was $0.012B, a 85.49% decline year-over-year.

  • BioNTech SE 2023 EBIT was 0.747B, a 94.39% decline from 2022.
  • BioNTech SE 2022 EBIT was 13.32B, a 26.33% decline from 2021.
  • BioNTech SE 2021 EBIT was 18.082B, a 19306.82% decline from 2020.

EBIT can be defined as earnings before interest and taxes.

BioNTech SE EBIT 2019-2024 | BNTX

  • BioNTech SE 2023 EBIT was 0.747B, a 94.39% decline from 2022.
  • BioNTech SE 2022 EBIT was 13.32B, a 26.33% decline from 2021.
  • BioNTech SE 2021 EBIT was 18.082B, a 19306.82% decline from 2020.

EBIT can be defined as earnings before interest and taxes.